Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Dubuisson

Showing results (121-130 of 241) with videos related to

Pageof 25
Sort By:
The Journal of General Virology|August 19, 2007
Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteinsDavid Delgrange, André Pillez, Sandrine Castelain, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2004
Incomplete humoral immunity against hepatitis C virus is linked with distinct recognition of putative multiple receptors by E2 envelope glycoproteinTae-Hwe Heo, Jae-Hoon Chang, Jae-Woo Lee, et al.
Microorganisms|February 12, 2021
Fluoxetine Can Inhibit SARS-CoV-2 In VitroArthur Dechaumes, Magloire Pandoua Nekoua, Sandrine Belouzard, et al.
Cells|October 27, 2019
Hepatitis C Virus Improves Human Tregs Suppressive Function and Promotes Their Recruitment to the LiverLaurissa Ouaguia, Olivier Moralès, Lynda Aoudjehane, et al.
Frontiers in Microbiology|October 17, 2022
A reporter cell line for the automated quantification of SARS-CoV-2 infection in living cellsLowiese Desmarets, Nathalie Callens, Eik Hoffmann, et al.
Infectious Agents and Cancer|December 19, 2021
BacMam virus-based surface display for HCV E2 glycoprotein induces strong cross-neutralizing antibodies and cellular immune responses in vaccinated miceEbrahim Kord, Farzin Roohvand, Jean Dubuisson, et al.
Journal of Virology|January 5, 2002
Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell linesSabine Wellnitz, Bettina Klumpp, Heidi Barth, et al.
Cellular and Molecular Life Sciences : CMLS|January 15, 2021
Ultrastructural modifications induced by SARS-CoV-2 in Vero cells: a kinetic analysis of viral factory formation, viral particle morphogenesis and virion releaseSébastien Eymieux, Yves Rouillé, Olivier Terrier, et al.
The Journal of General Virology|March 11, 2006
Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particlesCynthia Chapel, Céline Garcia, Philippe Roingeard, et al.
Cellular Microbiology|January 28, 2016
Identification of class II ADP-ribosylation factors as cellular factors required for hepatitis C virus replicationRayan Farhat, Karin Séron, Juliette Ferlin, et al.
Pageof 25

Showing results (121-130 of 241) with videos related to

Sort By:
Pageof 25
The Journal of General Virology|August 19, 2007
Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteinsDavid Delgrange, André Pillez, Sandrine Castelain, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2004
Incomplete humoral immunity against hepatitis C virus is linked with distinct recognition of putative multiple receptors by E2 envelope glycoproteinTae-Hwe Heo, Jae-Hoon Chang, Jae-Woo Lee, et al.
Microorganisms|February 12, 2021
Fluoxetine Can Inhibit SARS-CoV-2 In VitroArthur Dechaumes, Magloire Pandoua Nekoua, Sandrine Belouzard, et al.
Cells|October 27, 2019
Hepatitis C Virus Improves Human Tregs Suppressive Function and Promotes Their Recruitment to the LiverLaurissa Ouaguia, Olivier Moralès, Lynda Aoudjehane, et al.
Frontiers in Microbiology|October 17, 2022
A reporter cell line for the automated quantification of SARS-CoV-2 infection in living cellsLowiese Desmarets, Nathalie Callens, Eik Hoffmann, et al.
Infectious Agents and Cancer|December 19, 2021
BacMam virus-based surface display for HCV E2 glycoprotein induces strong cross-neutralizing antibodies and cellular immune responses in vaccinated miceEbrahim Kord, Farzin Roohvand, Jean Dubuisson, et al.
Journal of Virology|January 5, 2002
Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell linesSabine Wellnitz, Bettina Klumpp, Heidi Barth, et al.
Cellular and Molecular Life Sciences : CMLS|January 15, 2021
Ultrastructural modifications induced by SARS-CoV-2 in Vero cells: a kinetic analysis of viral factory formation, viral particle morphogenesis and virion releaseSébastien Eymieux, Yves Rouillé, Olivier Terrier, et al.
The Journal of General Virology|March 11, 2006
Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particlesCynthia Chapel, Céline Garcia, Philippe Roingeard, et al.
Cellular Microbiology|January 28, 2016
Identification of class II ADP-ribosylation factors as cellular factors required for hepatitis C virus replicationRayan Farhat, Karin Séron, Juliette Ferlin, et al.
Pageof 25